Click here for YNHH home page.


Search this site for:






Marketing &
Communications
contact information

Main office:
(203) 688-2488
Call for after hours
beeper no.

Fax:
(203) 688-2491

Patient conditions
after hours:
(203) 688-4177

Media Coordinator:
Mark D'Antonio
(203) 688-2493

Assistant Director:
Katie Murphy
(203) 688-2492



Phone Numbers

Directory assistance
(203) 688-4242

Patient information
(203) 688-4177

Adult emergency
(203) 688-2222

Children's emergency
(203) 688-3333

Admitting
(203) 688-2221

Children's admitting
(203) 688-3331

Psychiatric admitting
(203) 688-9907



Mailing address:
Yale-New Haven Hospital
20 York Street
New Haven, CT
06510-3202

Press releases

Yale-New Haven Hospital news release
Release date: October 7, 2005
Media contact: Mark D'Antonio, (203) 688-2493

Yale-New Haven Hospital initiates Connecticut's first full-time inpatient diabetes treatment team

Dr. Olga Sakharova, fellow, department of endocrinology; Dr. Samantha Demauro, fellow, department of endocrinology; Dr. Silvio Inzucchi, director and professor of medicine, department of endocrinology; Gael Ulisse, APRN; Dr. Susan Brian, fellow, department of endocrinology; Helen Psarakis, APRN

Dr. Olga Sakharova, fellow, department of endocrinology; Dr. Samantha Demauro, fellow, department of endocrinology; Dr. Silvio Inzucchi, director and professor of medicine, department of endocrinology; Gael Ulisse, APRN; Dr. Susan Brian, fellow, department of endocrinology; Helen Psarakis, APRN

Due to the growing national incidence of diabetes, American hospitals are increasingly admitting diabetic patients for a variety of other illnesses or surgeries. Until they are admitted, many of these patients aren't even aware that they have diabetes, a disease in which the body does not produce or properly use insulin. Insulin is a hormone needed to convert sugar, starches and other food into energy for daily life.

To address the needs of its growing number of diabetic patients, Yale-New Haven Hospital (YNHH) has initiated Connecticut's first full-time dedicated inpatient diabetes treatment team. The team's goals are to control a patient's blood sugar levels during hospitalization so patients heal quicker with fewer complications, and to educate them about their diabetes for a successful transition from inpatient to outpatient.

The team began serving patients in July, and represents a joint effort between Yale-New Haven Hospital and the Yale University School of Medicine. The program is headed by Silvio Inzucchi, MD, clinical director, section of endocrinology and professor of medicine. The team also includes Gael Ulisse, advanced practice registered nurse (APRN), diabetes nurse practitioner, and Helen Psarakis, APRN, diabetes nurse educator. They work extensively with physicians and nurses to improve the quality of diabetes control provided to inpatients on all medical and surgical units at Yale-New Haven Hospital. They also educate patients and staff about the disease.

Diabetes is a growing health problem in the United States, and patients at Yale-New Haven Hospital reflect this trend. In 2004, nearly 21 percent of all adult patients hospitalized at Yale-New Haven Hospital had diabetes; nationally, it is estimated that 23 percent of hospitalized adult patients have diabetes. In the past 10 years, the number of patients admitted to Yale-New Haven Hospital with diabetes has climbed by nearly 50 percent.

"We have discovered that strict glucose control accelerates patients' recovery," said Dr. Inzucchi. "By supplementing the patient's regular care team with a dedicated team of diabetes specialists, we decrease complications from surgery or other illnesses, decrease rates of infection and shorten their stay in the hospital."

In the past, maintaining strict control of blood sugar levels was not seen as an essential part of the patient's treatment. However, research has shown that maintaining optimal blood sugar levels improves patient care and recovery time. The traditional approach of controlling elevated blood sugar levels in hospitalized patients relied on intermittent use of short-acting insulin. A more aggressive approach to glucose control, using different insulin types and continuous insulin infusions, together with frequent monitoring and blood sugar readings, has the potential to be more effective in reducing the hospital length of stay, infection rates and overall mortality.

"We used to treat elevated blood sugars in patients for whom diabetes was a secondary condition not as a major problem, but as a minor one that stayed in the background," said Tom Balcezak, MD, assistant chief of staff at Yale-New Haven Hospital. "But that background problem has a major impact on the patient's primary illness and condition. This new team will provide the essential supplementary care that can help the patient's primary team develop a treatment plan to tighten control over the patient's glucose and also send that patient home with a plan to live healthfully with the disease."

Reporters: For more information on this release, contact Mark D'Antonio, (203) 688-2493.


Return to: News Release Index


Health News Service. A brief synopsis of potential story ideas.

Last revised: October 7, 2005 (mv)


Copyright 1999-2006.
Top of Page. Y-NHH. YNHHS. Medical Center. Site Editor.
Home page
Staff directory
Directions and parking
Online resources
Yale New Haven Health System
  Need a doctor?
Search
Comments
Top of page
Yale-New Haven Medical Center